[SRNE] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -117.11%
YoY- -231.77%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 18,385 14,255 7,721 6,143 6,246 4,874 988 62.75%
PBT -38,946 2,212 -68,900 -145,810 -33,574 -25,499 -20,027 11.71%
Tax 1,463 -206 -276 -178 -948 -1,696 -1,637 -
NP -40,815 2,510 -65,195 -108,071 -32,574 -23,064 -18,390 14.20%
Tax Rate - 9.31% - - - - - -
Total Cost 59,200 11,745 72,916 114,214 38,820 27,938 19,378 20.44%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -222.00 17.61 -844.39 -1,759.25 -521.52 -473.20 -1,861.34 -29.82%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.12 0.01 -0.36 -0.88 -0.38 -0.45 -0.48 -20.62%
EPS Diluted -0.12 0.01 -0.36 -0.88 -0.38 -0.45 -0.48 -20.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.